Chiasma, Inc. (CHMA)
Stock Price:
$4.65 USD
0.28 (6.29%)
Updated Aug 3, 2020 4:00 PM EDT - Market closed
After-hours: $4.62 -0.03 (-0.54%) Aug 3, 5:25 PM
Key Info
| Market Cap |
254.38M |
| Revenue (ttm) |
n/a |
| Net Income (ttm) |
-42.96M |
| Shares Out |
42.27M |
| EPS (ttm) |
-1.11 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Aug 3, 2020 |
| Last Price |
$4.65 |
| Previous Close |
$4.37 |
| Change ($) |
0.28 |
| Change (%) |
6.29% |
| Day's Open |
4.41 |
| Day's Range |
4.38 - 4.76 |
| Day's Volume |
509,311 |
| 52-Week Range |
2.88 - 7.75 |
More Stats
| Market Cap |
254.38M |
| Enterprise Value |
175.12M |
| Earnings Date (est) |
Aug 6, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
42.27M |
| Float |
35.40M |
| EPS (basic) |
-1.1 |
| EPS (diluted) |
-1.11 |
| FCF / Share |
-0.95 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
2.17M |
| Short Ratio |
1.27 |
| Short % of Float |
5.04% |
| Beta |
1.49 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
n/a |
| PB Ratio |
2.57 |
| Revenue |
n/a |
| Operating Income |
-44.37M |
| Net Income |
-42.96M |
| Free Cash Flow |
-40.23M |
| Net Cash |
79.26M |
| Net Cash / Share |
1.45 |
| Gross Margin |
n/a |
| Operating Margin |
n/a |
| Profit Margin |
n/a |
| FCF Margin |
n/a |
| ROA |
-39.17% |
| ROE |
-87.87% |
| ROIC |
-85.50% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (4)
| Buy |
4 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$16.25*
(249.84% upside)
Low
11.0
Current: $4.65
High
19.0
Target: 16.25
*Average 12-month price target from 4 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|
| Revenue | - | - | - | - | - | 13.17 | 73.13 |
| Revenue Growth | - | - | - | - | - | -82% | - |
| Gross Profit | - | - | - | - | - | 13.17 | 73.13 |
| Operating Income | -37.58 | -32.34 | -28.13 | -61.31 | -35.45 | -1.83 | 38.61 |
| Net Income | -36.32 | -31.26 | -26.83 | -61.11 | -35.91 | -2.01 | 36.18 |
| Shares Outstanding | 34.20 | 24.40 | 24.37 | 24.32 | 11.15 | 0.04 | 0.04 |
| Earnings Per Share | -1.06 | -1.28 | -1.10 | -2.51 | -3.25 | -66.21 | -125.29 |
| Operating Cash Flow | -35.01 | -24.09 | -24.42 | -51.96 | -33.30 | -6.40 | 46.19 |
| Capital Expenditures | -0.31 | -0.01 | -0.02 | -2.83 | -0.26 | 0.08 | -0.01 |
| Free Cash Flow | -35.32 | -24.10 | -24.45 | -54.79 | -33.56 | -6.32 | 46.18 |
| Cash & Equivalents | 92.38 | 41.66 | 66.94 | 92.98 | 149 | 40.16 | 12.85 |
| Net Cash / Debt | 92.38 | 41.66 | 66.94 | 92.98 | 149 | 40.16 | 12.85 |
| Assets | 98.83 | 63.26 | 69.88 | 96.76 | 153 | 41.40 | 14.66 |
| Liabilities | 13.06 | 29.13 | 7.41 | 11.03 | 10.29 | 8.93 | 14.56 |
| Book Value | 85.77 | 34.12 | 62.47 | 85.73 | 143 | -72.02 | -70.64 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Chiasma, Inc. |
| Country |
United States |
| Employees |
49 |
| CEO |
Raj Kannan |
Stock Information
| Ticker Symbol |
CHMA |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Biotechnology |
| Unique Identifier |
NASDAQ: CHMA |
| IPO Date |
July 16, 2015 |
Description
Chiasma, Inc., a clinical late-stage biopharmaceutical company, focuses on developing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide. The company develops oral octreotide capsules for adult patients under the MYCAPSSA name, which is in Phase III clinical trials for the treatment of acromegaly, a condition that results in the body's production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Needham, Massachusetts.